Literature DB >> 23074391

Non-invasive cardiac imaging technologies for the assessment of myocardial viability: a summary of evidence-based analyses.

.   

Abstract

Entities:  

Year:  2010        PMID： 23074391      PMCID： PMC3377565     

Source DB:  PubMed          Journal:  Ont Health Technol Assess Ser        ISSN： 1915-7398


× No keyword cloud information.
  16 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 2.  Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology.

Authors:  S Richard Underwood; Jeroen J Bax; Jürgen vom Dahl; Michael Y Henein; Juhani Knuuti; Albert C van Rossum; Ernst R Schwarz; Jean-Louis Vanoverschelde; Ernst E van der Wall; William Wijns
Journal:  Eur Heart J       Date:  2004-05       Impact factor: 29.983

Review 3.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 4.  PET imaging in cardiology.

Authors:  George N Chacko
Journal:  Hell J Nucl Med       Date:  2005 Sep-Dec       Impact factor: 1.102

Review 5.  Clinical assessment of myocardial hibernation.

Authors:  Arend F L Schinkel; Jeroen J Bax; Don Poldermans
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

6.  Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.

Authors:  Harald P Kühl; Claudia S A Lipke; Gabriele A Krombach; Marcus Katoh; Thomas F Battenberg; Bernd Nowak; Nicole Heussen; Arno Buecker; Wolfgang M Schaefer
Journal:  Eur Heart J       Date:  2006-01-24       Impact factor: 29.983

7.  Regional variation in self-reported heart disease prevalence in Canada.

Authors:  Chi-Ming Chow; Linda Donovan; Doug Manuel; Helen Johansen; Jack V Tu
Journal:  Can J Cardiol       Date:  2005-12       Impact factor: 5.223

Review 8.  Assessment of myocardial viability in chronic ischemic heart disease: current status.

Authors:  V Rizzello; D Poldermans; J J Bax
Journal:  Q J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 2.346

9.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

Authors:  R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

Review 10.  Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.

Authors:  Munir Ghesani; E Gordon Depuey; Alan Rozanski
Journal:  Echocardiography       Date:  2005-02       Impact factor: 1.724
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.